Vicky Torrano

1.1k total citations · 1 hit paper
9 papers, 893 citations indexed

About

Vicky Torrano is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Vicky Torrano has authored 9 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in Vicky Torrano's work include CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Viral-associated cancers and disorders (5 papers). Vicky Torrano is often cited by papers focused on CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Viral-associated cancers and disorders (5 papers). Vicky Torrano collaborates with scholars based in United States. Vicky Torrano's co-authors include Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, Adrian P. Gee, Hao Liu, Carlos A. Ramos, Catherine M. Bollard, Stephen Gottschalk, Youli Zu and George Carrum and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Vicky Torrano

8 papers receiving 881 citations

Hit Papers

Sustained Complete Responses in Patients With Lymphoma Re... 2013 2026 2017 2021 2013 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicky Torrano United States 6 791 389 273 187 181 9 893
Meng‐Fen Wu United States 11 948 1.2× 581 1.5× 317 1.2× 251 1.3× 164 0.9× 16 1.1k
Clare Taylor United States 8 751 0.9× 356 0.9× 133 0.5× 201 1.1× 207 1.1× 15 942
Premal Lulla United States 17 702 0.9× 290 0.7× 100 0.4× 231 1.2× 258 1.4× 64 938
Sandhya Sharma United States 10 641 0.8× 242 0.6× 87 0.3× 261 1.4× 251 1.4× 21 735
Kitsada Wudhikarn Thailand 14 541 0.7× 144 0.4× 136 0.5× 125 0.7× 125 0.7× 55 742
Xia Mao China 16 512 0.6× 180 0.5× 84 0.3× 123 0.7× 235 1.3× 66 741
Brock Lanier United States 5 1.0k 1.3× 439 1.1× 62 0.2× 343 1.8× 294 1.6× 8 1.1k
Maria‐Luisa Schubert Germany 20 1.0k 1.3× 335 0.9× 85 0.3× 339 1.8× 397 2.2× 40 1.2k
Don A. Stevens United States 15 469 0.6× 146 0.4× 232 0.8× 41 0.2× 234 1.3× 100 798
Susanne H.C. Baumeister United States 10 637 0.8× 598 1.5× 50 0.2× 68 0.4× 175 1.0× 19 1.0k

Countries citing papers authored by Vicky Torrano

Since Specialization
Citations

This map shows the geographic impact of Vicky Torrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Torrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Torrano more than expected).

Fields of papers citing papers by Vicky Torrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky Torrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Torrano. The network helps show where Vicky Torrano may publish in the future.

Co-authorship network of co-authors of Vicky Torrano

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky Torrano. A scholar is included among the top collaborators of Vicky Torrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky Torrano. Vicky Torrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
McLaughlin, Lauren P., Rayne H. Rouce, Stephen Gottschalk, et al.. (2018). EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation. Blood. 132(22). 2351–2361. 56 indexed citations
2.
Bollard, Catherine M., Tamara Tripic, Carolina Colli Cruz, et al.. (2018). Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma. Journal of Clinical Oncology. 36(11). 1128–1139. 140 indexed citations
3.
Ramos, Carlos A., Barbara Savoldo, Vicky Torrano, et al.. (2016). Clinical responses with T lymphocytes targeting malignancy-associated κ light chains. Journal of Clinical Investigation. 126(7). 2588–2596. 234 indexed citations
4.
Rouce, Rayne H., Birju Mehta, Sandhya Sharma, et al.. (2016). Rapidly-Generated EBV-Specific T Cells (EBVST-cells) to Treat Type 2 Latency Lymphoma. Blood. 128(22). 2990–2990.
5.
Perna, Serena, Stephen Gottschalk, Vicky Torrano, et al.. (2015). Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Lymphoma Post Allogeneic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 21(2). S148–S148. 2 indexed citations
6.
Bollard, Catherine M., Stephen Gottschalk, Vicky Torrano, et al.. (2013). Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins. Journal of Clinical Oncology. 32(8). 798–808. 384 indexed citations breakdown →
7.
Cruz, Carolina Colli, Patrick J. Hanley, Hao Liu, et al.. (2010). Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience. Cytotherapy. 12(6). 743–749. 60 indexed citations
8.
Cruz, Carolina Colli, Patrick J. Hanley, Hao Liu, et al.. (2009). Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: A 10 Year Experience.. Blood. 114(22). 3212–3212. 1 indexed citations
9.
Bollard, Catherine M., M. Helen Huls, Elizabeth L. Buza, et al.. (2006). Administration of Latent Membrane Protein 2–Specific Cytotoxic T Lymphocytes to Patients with Relapsed Epstein-Barr Virus–Positive Lymphoma. Clinical Lymphoma & Myeloma. 6(4). 342–347. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026